- Acquisition successfully closed for enterprise value of $5.1 billion 
- Siemens expands AI-powered Siemens Xcelerator portfolio with end-to-end  digital thread that connects data from research through to production in  Life Sciences
- Combined capabilities expected to accelerate scientific innovation and drive  long-term growth 
- Acquisition is another milestone of Siemens’ ONE Tech Company program  expanding Siemens’ offerings into the life sciences industry with stronger  customer focus, faster innovations and higher profitable growth 
 
Siemens AG announced today that it has completed the acquisition of Dotmatics, a  leading provider of Life Sciences R&D software headquartered in Boston and  portfolio company of global software investor Insight Partners, for an enterprise  value of $5.1 billion. With the transaction now completed, Dotmatics will form part of  Siemens’ Digital Industries Software business, marking a significant expansion of  Siemens’ industry-leading Product Lifecycle Management (PLM) portfolio into the  rapidly growing and complementary Life Sciences market.
The acquisition of Dotmatics strengthens Siemens’ position as a global leader in AI- powered PLM software and enables Siemens to scale its technologies into Life  Sciences to fully address growth opportunities in this market. Dotmatics’ Scientific  Intelligence Platform, Luma, and its industry-leading scientific applications enable  AI-powered multi-modal drug development, seamless collaboration, and  contextualized data creating a connected digital thread across the research-to- production value chain.
“With Dotmatics, we’re building a new era of innovation in Life Sciences. From  research through to production – we’re creating a unique, end-to-end digital thread:  We combine Dotmatics’ scientific intelligence with our industrial AI technologies and  digital twins,” said Roland Busch, President and CEO of Siemens AG. “This will  allow us to help our customers accelerate breakthroughs, reduce development  cycles, and bring life-saving pharmaceuticals faster and more affordably to the  market.”
This transaction expands Siemens’ total addressable market for industrial software  by $11 billion and aligns with ‘ONE Tech Company’, the company’s strategic growth  program, aimed at accelerating innovation and creating value across industries.  Dotmatics is expected to generate more than $300 million in revenue in fiscal year  2025 with an adjusted EBITDA margin above 40 percent, further enhancing  Siemens’ growth profile. Dotmatics’ revenue growth and high profitability will be  immediately accretive to Siemens’ growth, EBITDA margins and free cash flow, prior  to any synergies and special items. Siemens expects substantial revenue synergies:  Medium-term revenue synergies expected of around $100 million per year  accelerating to over $500 million per year in the long-term.